title: New approach in patients with polycystic ovaries, lessons for everyone.
abstract: In vitro maturation is a safe and simple procedure for both the clinician and the patient. The discrepancy between the early clinical results and today's pregnancy rates (PR) of 30% is primarily due to the following modification of the original protocol recently reported by several groups: Priming with FSH and hCG, timing oocyte collection from follicles larger than 12 mm in diameter, and using blastocyst transfer. Furthermore, the endometrial priming should start 2 days before oocyte pick-up. This provides a PR of 40% per ET.
authors: Copenhagen Fertility Center, Copenhagen, Denmark. svend@lindenberg.dk
authors: Svend
authors: S
authors: Lindenberg
mesh_terms: D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D004717:Endometrium / Q000502:physiology; D005260:Female; D043373:Follicle Stimulating Hormone, Human / Q000627:therapeutic use; D006801:Humans; D059471:In Vitro Oocyte Maturation Techniques / Q000379:methods*; D007247:Infertility, Female / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy*; D054315:Oocyte Retrieval / Q000379:methods; D009865:Oocytes / Q000166:cytology*; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000503:physiopathology*; D011247:Pregnancy; D018873:Pregnancy Rate
chemical_list: D006063:Chorionic Gonadotropin; D043373:Follicle Stimulating Hormone, Human